INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo RENAGEL Tablets

For full prescribing information refer to the package insert approved by the medicines regulatory authority. This document has not yet been made available to us.

SCHEDULING STATUS:
no data

PROPRIETARY NAME
(and dosage form):

RENAGEL Tablets

COMPOSITION:
Each tablet contains
sevelamer hydrochloride 800,0 mg

ATC CLASSIFICATION:
V03AE02

PRESENTATION/PACK SIZE:
no data

REGISTRATION NUMBER:
41/34/0558

APPLICANT:
LEBASI PHARMACEUTICALS cc

MANUFACTURER:
no data

AVAILABILITY:
no data

DATE OF REGISTRATION:
no data

SOURCE:
REGISTRAR OF MEDICINES
12.43 Notification of Registration Oct08 v1.doc        Nov 2008

Date posted: August 2014

INTERNATIONAL LINKS
: (cut and paste the URL)

NOTE the content of these links are for reference only and may not apply to the registration criteria pertaining to The Medicines Control Council in South African.

The electronic Medicines Compendium (eMC)
EMC: http://www.medicines.org.uk/emc/document.aspx?documentid=18014

BOOTS Web MD: http://drugs.webmd.boots.com/drugs/drug-15333-Renagel+800mg+tablets.aspx?drugid=15333&drugname=Renagel%2b800mg%2btablets&source=2&isTicTac=True

NHS Choices: http://www.nhs.uk/medicine-guides/pages/MedicineOverview.aspx?condition=High%20phosphate%20levels&medicine=Sevelamer%20hydrochloride&preparationSevelamer%20800mg%20tablets

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2014